10-year disease course in patients with short disease duration of rheumatoid arthritis.

被引：0
|
作者：
Odegård, S [1 ]
Uhlig, T [1 ]
Kvien, TK [1 ]
Finset, A [1 ]
机构：
[1] Diakonhjemmet Hosp, Natl Resource Ctr Rehabil Rheumatol, Oslo, Norway
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
185
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [31] Risk factors for cardiovascular disease in Chilean patients with rheumatoid arthritis.
    Cisternas, M
    Gutierrez, MA
    Klassen, J
    Acosta, AM
    Jacobelli, S
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S153 - S153
  • [32] Hyperuricemia As a Risk Factor for Cardiovascular Disease in Patients With Rheumatoid Arthritis.
    Kuo, Daniel
    Crowson, Cynthia S.
    Gabriel, Sherine E.
    Matteson, Eric L.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S158 - S158
  • [33] The evolution of functional capacity in relation to disease activity over the course of rheumatoid arthritis.
    Finckh, Axel
    Bansback, Nickolas J.
    Liang, Matthew H.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S185 - S186
  • [34] EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH CONCOMITANT INTERSTITIAL LUNG DISEASE: 10-YEAR EXPERIENCE AT SINGLE CENTRE
    Kabia, Angela R.
    Yusof, Md Yuzaiful Md
    Dass, Shouvik
    Vital, Edward M.
    Beirne, Paul
    Emery, Paul
    [J]. RHEUMATOLOGY, 2015, 54 : 86 - 86
  • [35] The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study
    Sella A Provan
    Kristin Angel
    Sigrid Ødegård
    Petter Mowinckel
    Dan Atar
    Tore K Kvien
    [J]. Arthritis Research & Therapy, 10
  • [36] The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis:: a 10-year longitudinal study
    Provan, Sella A.
    Angel, Kristin
    Odegard, Sigrid
    Mowinckel, Petter
    Atar, Dan
    Kvien, Tore K.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2008, 10 (03)
  • [37] EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH CONCOMITANT INTERSTITIAL LUNG DISEASE: 10-YEAR EXPERIENCE AT SINGLE CENTRE
    Yusof, M. Y. Md
    Kabia, A.
    Dass, S.
    Vital, E. M.
    Beirne, P.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 251 - 251
  • [38] The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients
    Arts, Elke E. A.
    Fransen, Jaap
    den Broeder, Alfons A.
    Popa, Calin D.
    van Riel, Piet L. C. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 998 - 1003
  • [39] Validation of minimal disease activity for rheumatoid arthritis.
    Wells, G
    Boers, M
    Simon, L
    Strand, V
    Tugwell, P
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S657 - S657
  • [40] Novel disease activity biomarkers of rheumatoid arthritis.
    Dickson, Marion C.
    Hughes, Fiona
    Warnock, Linda
    Sharp, Catriona
    Montgomery, Doug
    Inma, Rioja
    Binks, Michael H.
    Wilson, Anthony G.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S181 - S181
12345